SLC2A5 and neoplasm: According to data from the UALCAN database, LUAD patients’ tumor tissues had hypomethylation of SLC2A1, SLC2A2, SLC2A5, SLC2A6, SLC2A7, SLC2A11 and hypermethylation of SLC2A3, SLC2A10, and SLC2A14 compared to normal tissues (Figure 6).